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ABSTRACT
We investigated the changes in brain oxygen tension (ptiO2) after ventilation with pure O2 in order
to (1) clarify the pathophysiology of O2 exchange in the cerebral microcirculation; and (2) investi-
gate the relationship between brain O2 tension, O2 delivery, and consumption in steady-state con-
ditions during stepwise cerebral blood flow (CBF) reductions. A swine model was developed to re-
duce CBF in three stable steps: (1) baseline (CBF 100%), (2) CBF of 50–60% of baseline, and (3)
CBF of ,30% of baseline. CBF was reduced by infusing saline into the left lateral ventricle through
a catheter connected with an infusion pump. At each step, hyperoxia was tested by increasing the
inspired oxygen fraction up to 100%, PtiO2 reflected the CBF reductions, since it was respectively
27.95 ( 6 10.15), 14.77 ( 6 3.58), and 3.45 ( 6 2.89) mm Hg during the three CBF steps. Hyperoxia was
followed by an increase in ptiO2, although the increase was significantly lower when hyperoxia was
applied during progressive ischemia. O2 supply to the brain did not change during hyperoxia. Ar-
teriovenous oxygen difference (AVDO2) decreased during the phases of intact CBF and moderate
impairment, but not during the phase of severe CBF reduction. In conclusion, ptiO2 reductions
closely reflect the imbalance between oxygen delivery and demand; this implies a link between low
ptiO2 and defective O2 supply due to impaired CBF. However, this relation is not necessarily reci-
procal, since manipulating brain oxygen tension does not always influence brain oxygen delivery,
as in the case of ventilation with pure oxygen.
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INTRODUCTION
ISCHEMIA has been identified as a pathway of cerebraldamage after head injury (Graham et al., 1978; Bouma
et al., 1991). Therefore, one of the major aims of research
into severe head injury is to achieve a better under-
standing of how brain metabolism is affected and to as-
sess the adequacy of the transport of oxygen and other
energy substrates to the brain parenchyma. This is based
on the concept that ensuring cerebral oxygenation and an
adequate supply of metabolites is the basis for maintain-
ing the viability and function of the damaged CNS.
Global monitoring provides an indirect estimate of the
adequacy of substrate supply to the brain. Brain oxygen
tension (ptiO2) can be measured locally using a Clark
electrode implanted in the cerebral parenchyma. The
method has been validated for use in humans and has
been confirmed as a reliable and stable indicator of local
oxygenation (Dings et al., 1997, 1998). PtiO2 monitor-
ing is useful to assess the efficacy of treatments based on
their ability to restore adequate ptiO2 levels (Kiening et
al., 1997; Zauner et al, 1997; Stocchetti et al., 1998).
Interest has been renewed on the effect of arterial hy-
peroxia, obtained by ventilation with pure oxygen, on
brain oxygenation. The ptiO2 response to hyperoxia
varies widely in different patients; it may also vary con-
siderably during the clinical course in head injury (Van
Santbrink et al., 1996). However, the pathophysiology of
the oxygen reactivity and the meaning of its variability
are not clearly understood. Arterial hyperoxia has been
used in order to elucidate its effect on cerebral blood flow
(CBF), cerebral metabolism, and their coupling. This pro-
cedure markedly increases ptiO2 and may also enhance
O2 delivery to the neurons (Menzel et al., 1999).
Our group developed a swine model of stepwise re-
duction of CBF, structured to achieve three steps of sta-
ble CBF: the first is intact CBF, the second a mild CBF
reduction, and the third a severe CBF impairment. The
model can be used to explore the interactions between
ptiO2, oxygen delivery and consumption, and blood flow
in stable conditions.
The present experiment was designed to investigate the
effects of arterial hyperoxia obtained by ventilation with
pure oxygen on cerebral oxygenation. Specifically, we
sought to gain further insight into the pathophysiology of
oxygen exchange in brain tissue during mild and severe
CBF impairment while also assessing how changes in
brain oxygen tension are related to brain oxygen deliv-
ery and consumption when hyperoxia is applied during
intact, moderately reduced, or severely impaired CBF.
MATERIALS AND METHODS
The experiments were conducted in accordance with the
guidelines for animal research published by the European
Union and acknowledged by Italian Law no. 116/92.
Seven 8-week-old domestic pigs, weighing 18–22 kg,
were used. They had free access to food and water until
the night before the experiment. Thirty minutes before
the induction of anesthesia they were given an intramus-
cular bolus of 100 mg of ketamine. This ensured ade-
quate sedation before general anesthesia, which was in-
duced with propofol (2 mg/kg) and succinylcholine (1
mg/kg) and maintained with isoflurane 1.0%; myorelax-
ation during the experiment was maintained by 0.3
mg/kg/h pancuronium bromide. An orotracheal tube was
positioned, and ventilation was administered with a con-
trolled volume modality to achieve paCO2 30–35 mm Hg.
Inspiratory oxygen fraction (FiO2) was kept at 25% and
30% to obtain a paO2 of 100–120 mm Hg.
Placement of the Probes and Monitoring
Deep branches of the carotid artery and the jugular vein
were surgically exposed and cannulated for monitoring
arterial pressure, arterial blood gases, arterial hemoglo-
bin oxygen saturation (SaO2), and infusion of fluids.
Saline was infused at the rate of 3 mL/kg/h. Rectal tem-
perature was monitored and kept at 37.5–38.5°C using
heating pads. The animals were placed in the prone po-
sition and a linear incision was made along the midline
from the inion to the nasion. The scalp was exposed, and
three burr holes were placed 1.5 cm from the midline on
the right side through and across the coronal suture. Two
more burr holes were made: one through the sagittal su-
ture and the other through the left coronal suture (1.5 cm
from the midline). Through a dural incision in the cere-
bral parenchyma (from the front to the rear and on the
right side), we placed the tips of the CBF probe, the ptiO2
probe, and the intracranial pressure (ICP) transducer.
Through the burr hole on the left, a ventricular catheter
was placed and connected to an infusion pump. The burr
hole through the sagittal suture gave access to the supe-
rior sagittal sinus and was punctured for monitoring ve-
nous blood gases and venous hemoglobin oxygen satu-
ration (SsO2). The position of the probes on the skull is
illustrated in Figure 1.
ICP was measured by a parenchymal fiberoptic device
(Camino Lab). PtiO2 was measured by a polarographic
Clark-type microcatheter (Licox, GMS). PtiO2 was al-
lowed to stabilize for 2 h after insertion of the catheter
and was corrected for rectal temperature during the ex-
periment. After the ptiO2 probe was removed, we checked
the sensitivity drift, as suggested by the manufacturer.
CBF was obtained continuously by laser Doppler flowme-
try (Peri-flux, Perimed) and was calculated as the change
in signal, as a percentage of the baseline.
Intermittent samples were drawn simultaneously from
superior sagittal sinus and from the artery in order to cal-
culate the arteriovenous oxygen difference (AVDO2), as
follows:
Hb*1.34*(SaO2% 2 SsO2%) 1 0.003(paO2 2 psO2)
Oxygen delivery to the brain (DO2) was calculated by mul-
tiplying arterial oxygen content by estimated CBF, as-
suming that the intact CBF amounted to 50 mL/100 g/min.
Cerebral electrical activity was monitored by a three-point
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EEG (Cerebro-trac, SDR Medical). Mean arterial pressure
(MAP), ICP, cerebral perfusion pressure (CPP), PtiO2,
end-tidal CO2, CBF, and temperature signals were filtered
by an analog digital converter (Mac Lab), and stored in a
Macintosh computer for offline analysis.
Induction of Progressive Ischemia
The model was developed to achieve progressive CBF
reduction in three stable steps: baseline (CBF 100%),
CBF 50–60% of baseline, and 20–30% of baseline. CBF
was reduced by inducing intracranial hypertension by in-
fusing saline (warmed to 38°C) into the left lateral ven-
tricle through a catheter connected with an infusion
pump. ICP was raised stepwise by boluses of saline. Once
the end point was reached (in terms of reduction of CPP
and CBF), the velocity of fluid infusion into the ventri-
cles was titrated to keep ICP, CPP, and CBF stable dur-
ing each step. Cushing response elicited by the ICP in-
crease was inhibited by the infusion of a-b blockers
(repeated bolus of labetalol 0.5–1 mg/kg).
At the end of the experiment, the animals were eu-
thanized by increasing the isoflurane concentration to 4%
and by infusing 60 mEq of KCl.
Hyperoxia Test
During each stage of the experiment (CBF 100%,
50–60%, and 20–30% of baseline), a hyperoxia test was
done. Once ICP, CPP, CBF, and ptiO2 were stable, the
inspired oxygen fraction was raised from 25–30% to
100%. Ventilation with pure oxygen was continued un-
til ptiO2 and the other intracranial parameters plateaued.
At the end of the test, FiO2 was brought back to the start-
ing value.
Statistics
Data were summarized as mean6 SD. Intracranial and
extracranial parameters at the three different CBF values
were compared using repeated-measures analysis of vari-
ance. A paired t test was used to compare differences be-
tween two groups. A p , 0.05 was considered as statis-
tically significant.
RESULTS
Description of the Model
Intracranial and stystemic variables. The course of in-
tracranial variables is shown in Figure 2. CPP and CBF
reduction reflected both the increase in ICP and the slight
reduction of MAP as a consequence of the use of a,b
blockers to blunt the Cushing reflex. The end points in
terms of reduction in CPP and thus in CBF were reached
stepwise. The two parameters were stable during the three
stages, which lasted (1) 49.8 (610.49), (2) 55.7 (619.8),
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FIG. 1. Probes and catheters position on the skull.
and (3) 48.28 (611.32) min. CBF reduction was accom-
panied by a parallel decrease in O2 delivery and by a sig-
nificant increase in AVDO2, consistent with impending
ischemia (Figure 3). The venoarterial difference of
paCO2 (VACO2) confirmed these findings, significantly
increasing from 10 (64) mm Hg at the baseline, to 14.5
(64.11) and to 31.2 (69.0) mm Hg in the two subse-
quent stages (p , 0.01). At the baseline and in the two
phases of CBF reduction, blood gases and internal tem-
perature remained constant; there was a small drop in he-
moglobin concentration, probably due to frequent blood
sampling (Table 1).
Electroencephalographic findings. Progressive CBF
impairment was accompanied by a sustained reduction in
EEG amplitude during the first phase (CBF 50–60% of
baseline) and by electrical silence during the second
(CBF 20–30% of baseline; Figure 4).
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FIG. 2. (Upper panel) Intracranial pressure (ICP) and mean arterial blood pressure (MAP) during the three steps of the ex-
periment. (Lower panel) Cerebral perfusion pressure (CPP) and cerebral blood flow measured by laser Doppler flowmetry
(LDF%). CBF was estimated by calculating the change of the signal as a percentage of baseline. Bar5 SD.
PtiO2 response to ischemia. In seven experiments,
eight ptiO2 catheters were used. One needed to be re-
placed because of malfunction, probably due to careless
storage. The others provided reliable readings through-
out the experiment, as confirmed by the final drift check.
In all cases the probe was allowed to stabilize for 2 h af-
ter insertion. PtiO2 reflected CBF reductions, since it was
27.95 (610.15) mm Hg with intact CBF. It declined to
14.77 (63.58) mm Hg during the first CBF reduction,
dropped to 3.45 (62.89) mm Hg during the second re-
duction, and finally fell to 0 mm Hg when CBF was com-
pletely abolished.
Response to Hyperoxia
PtiO2 response. Intracranial and extracranial parame-
ters that might have influenced the response to hyperoxia
remained stable during the maneuvers (Table 2). PaO2
increments caused by ventilation with pure oxygen were
not different during the three phases of the experiment.
Arterial hyperoxia was followed by a ptiO2 increase ex-
cept in one case when ptiO2 dropped close to 0 mm Hg
after severe CBF reduction. PtiO2 and paO2 changes dur-
ing hyperoxia in the three stages of the experiment are
presented in Figure 5. The response of ptiO2 followed a
wash-in curve with an early phase of rapid increase fol-
lowed by a flex-point and a plateau. In order to stan-
dardize our analysis of the behavior of ptiO2 after arte-
rial hyperoxia, we considered the rise in the first minute
after induction of hyperoxia (the phase of the highest re-
sponse). The increase in ptiO2 was significantly lower
when hyperoxia was applied during CBF reduction, and
this was confirmed when the values were corrected for
PaO2 as indicated by the following calculation:
(ptiO21st minute2 ptiO2base)/(paO2100%2 paO2base) * 100
where ptiO21st minute is the value after the first minute of
hyperoxia, ptiO2base is the value before hyperoxia,
paO2100% is O2 arterial partial pressure with ventilation
with pure O2 and paO2 base is O2 arterial partial pres-
sure before hyperoxia was induced (Figure 6).
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TABLE 1. BLOOD GASES, HEMOGLOBIN, AND INTERNAL TEMPERATURE
Hb (g/dl) PaO2 (mm Hg) PaCO2 (mm Hg) SaO2% pH T°C
CBF 100% 9.0 (61.25) 120 (619.9) 38 (62.58) 100 7.40 (60.064) 37.8 (60.30)
CBF 50–60% of baseline 8.3 (61.43) 121 (624.5) 37.1 (63.07) 100 7.41 (60.054) 37.5 (60.45)
CBF 20–30% of baseline 7.9 (61.13) 113 (626.9) 37.7 (61.97) 100 7.40 (60.044) 37.9 (0.29)
Repeated-measures analysis NS NS NS NS NS NS
CBF, cerebral blood flow; NS, not significant.
FIG. 3. Arteriovenous oxygen difference (AVDO2) and brain oxygen delivery (DO2). The latter was calculated by multiplying
arterial oxygen content by estimated CBF, assuming the intact CBF as 50 mL/100 g/min (p , 0.05).
DO2 and AVDO2. In each of the three steps of the ex-
periment, CBF showed a slight reduction during hyper-
oxia and a restoration of the original CBF at the end of
the hyperoxia test, as indicated in Figure 7. To clarify
whether the increase of ptiO2 due to hyperoxia reflected
an increased oxygen supply, we multiplied the arterial
oxygen content by the relative value of the CBF. O2 sup-
ply to the brain did not change during hyperoxia in any
of the three steps of the experiment (Figure 8, upper
panel). We evaluated the effects of arterial and cerebral
hyperoxia on oxygen extraction by comparing AVDO2
during normo- and hyperoxia for the three CBF levels.
AVDO2 decreased significantly during hyperoxia when
CBF was normal or mildly reduced; it remained un-
changed during severe CBF reduction (Figure 8, lower
panel).
DISCUSSION
Disturbances of oxygen utilization by the brain are a
common mechanism of damage after head injury
(Bergsneider et al., 1997; Bouma et al., 1991; Cormio et
al., 1999; Gopinath et al., 1994). Like in peripheral tis-
sues, this may be due to inadequate O2 uptake, inade-
quate O2 delivery, or mitochondrial dysfunctions (Pin-
sky, 1994). These disturbances have been amply reported
in the literature and have been associated with unfavor-
able outcome after head injury. However, a full charac-
terization and description of the pathophysiology of gas
exchange and metabolism in the brain is lacking, mak-
ing it hard to assess the real efficacy of treatments to re-
store appropriate O2 delivery.
In our experimental model, reduction of CBF was
achieved by injecting volume into the ventricular system,
a widely described technique (Maas et al., 1993). The pri-
mary aim of the model was to obtain reproducible steps
of CBF decline, stable enough to allow the study of PtiO2,
oxygen delivery and AVDO2 in response to superim-
posed perturbations and interventions.
The end points of CPP and CBF reduction were ob-
tained in all the animals studied, with only small varia-
tion. The continuous infusion of volume into the system
enabled us to maintain the desired CBF reduction and,
by administering a,b blockers, we were able to limit the
Cushing response, which would tend to raise CBF closer
to physiological levels by increasing arterial pressure and
heart rate through sympathetic activation. It might be ar-
gued that the use of labetalol may have caused an im-
pairment of autoregulation which could have affected
cerebral oxygenation. Findings on how the adrenergic
system affects cerebrovascular tone are often contradic-
tory, so it is difficult to assess the drug’s impact on au-
toregulation (Go, 1991). Blunting the Cushing response
was essential in this experiment in order to obtain 
the stepwise CBF reduction, and we do not know what
would happen to brain oxygen tension without the a,b
blocker.
PtiO2 values in case of intact CBF were around 20 mm
Hg; the value declined parallel to the flow reduction, con-
firming extensive reports about the ptiO2 threshold for
ischemia (Doppenberg et al., 1998; Kiening et al., 1996;
Maas et al., 1993; Valadka, 1998).
During these controlled “staircase” CBF reductions,
we were able to estimate brain oxygen delivery. How-
ever, as we do not know the absolute value of CBF, the
measure had to be extrapolated; nevertheless, with the
stable conditions and a global reduction of flow, this ex-
trapolation should give a close approximation of the
change in oxygen supply to the brain at different levels
of CBF. The symmetrical increase of AVDO2 further
confirms that there are situations where CBF becomes
progressively less able to meet the tissue’s metabolic de-
mand. AVDO2, for instance, was 7.01 (61.31) mL/100
mL during mild reduction of CBF and 8.16 (61.54)
mL/100 mL during marked flow reduction, in agreement
with the thresholds for ischemia reported elsewhere
(Gibbs et al., 1942; Robertson et al., 1989). Venous-ar-
terial difference in pCO2, which has been recently sug-
gested as an indicator of critical hypoperfusion and 
ischemia, also increased during the three stages of the ex-
periment (Weil et al., 1986; Zhang and Vincent, 1993).
PtiO2 increased after the induction of arterial hyper-
oxia, the extent of this rise depending on the initial CBF
value: it was close to 6 mm Hg/min when CBF was in-
tact and fell to 2.6 mm Hg/min when CBF was severely
compromised.
Our data on how ptiO2 reacts to hyperoxia may help
clarify the pathophysiology of ptiO2 readings provided
by polarographic sensors when progressive ischemia is
induced. Tissue oxygenation depends on the balance be-
tween microcirculatory O2 delivery and parenchymal O2
demand. The characteristics affecting O2 response are the
permeability of the tissue itself to O2 (depending on sol-
ubility and the O2 diffusion coefficient) and the spatial
distribution and activity of the mitochondria with respect
to the source of O2 (namely arterioles and capillaries;
Leach and Treacher, 1998; Treacher and Leach, 1998;
Lubbers, 1977; Pittman, 1999).
The diffusion gradient between the vessels and the tis-
sue should be higher in case of ischemia, so the ptiO2 re-
sponse to arterial hyperoxia would be expected to be
greater in case of low CBF and low baseline ptiO2, which
was not the case in our experiment. The different re-
sponse to hyperoxia during ischemia is thus consistent
with an increase in the diffusion distance due to a re-
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duction in microvasculature density per unit of tissue. We
therefore believe that the importance of the ptiO2 re-
sponse to hyperoxia provides further evidence that ptiO2
readings by the polarographic sensor are primarily the
expression of the spatial distribution and of the density
of arterioles and capillaries in the parenchyma. We have
confirmed the results of this animal study in patients suf-
fering head injury and subarachnoid hemorrhage, in
which the ptiO2 probe was placed in low-flow brain ar-
eas (Longhi et al., 1999).
The second issue we set out to address was the rela-
tionship between the changes in ptiO2 and oxygen de-
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FIG. 4. EEG patterns during the experiment. From the upper to the lower part of the figure, EEG during intact, moderately,
and severely reduced CBF. In each image, beside the real-time EEG signal, the average amplitude (AMP) and the highest dom-
inant frequency in the EEG signal (SPECTRUM) are presented.
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TABLE 2. MEAN ARTERIAL PRESSURE, INTRACRAN IAL PRESSURE, AND PACO2 DURING HYPEROXIA IN
THE THREE STAGES OF THE EXPERIMENT (NO SIGNIFICANT DIFFERENCES WERE DETECTED)
MAP (mm Hg) ICP (mm Hg) paCO2 (mm Hg)
Normoxia Hyperoxia Normoxia Hyperoxia Normoxia Hyperoxia
CBF 100% 107.8 (613.8) 110 (614.6) 8 (63.1) 7.3 (64.2) 38.2 (63.2) 36.4 (65.59)
CBF 50–60% 91.42 (612.7) 89.2 (614.6) 38.5 (66.5) 36.4 (66.77) 37.1 (63.07) 37.4 (64.11)
CBF 20–30% 75.28 (614.6) 74.1 (617.7) 45 (610) 45.5 (612.9) 37.7 (61.97) 39.8 (63.5)
MAP, mean arterial pressure; ICP, intracranial pressure; CBF, cerebral blood flow.
FIG. 5. Arterial O2 partial pressure (PaO2) in the upper panel and brain O2 tension (ptiO2) in the lower panel during ventila-
tion with inspired oxygen fractions of 25–30% and 100%.
livery to the brain, in particular whether the increase in
brain oxygen tension induced by arterial hyperoxia cor-
responded to an increase in the volumes of oxygen avail-
able for the tissue’s metabolic needs. One of the main
findings was that in conditions of moderate or deep CBF
reduction, raising O2 brain partial pressure did not nec-
essarily increase oxygen delivery. O2 supply is in fact the
product of arterial blood oxygen content and blood flow
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FIG. 6. PtiO2 rising in the first minute after induction of hyperoxia and the same value corrected for the change in paO2 using
the calculation reported in the text. *p , 0.05 by using repeated-measures analysis of variance for PtiO2 rising in the first minute.
**p , 0.05 for PtiO2 change corrected for paO2.
FIG. 7. CBF reductions during hyperoxia.
(CBF in this case). The increase in the O2 dissolved frac-
tion caused by arterial hyperoxia has a limited impact on
O2 content, which is due mainly to the fraction bound to
hemoglobin. Raising paO2 from 130 to 500 mm Hg in-
creases the O2 dissolved fraction by only 1.1 mL/dL (to
0.003 *paO2).
The second factor affecting O2 delivery is CBF which
decreased (albeit only slightly) after arterial hyperoxia
was induced in our experimental setting. This response
has already been reported: arterial hyperoxia caused cere-
bral vasoconstriction, hence a decrease in CBF (Jacob-
son et al., 1963, 1964). It follows that O2 brain delivery
cannot be increased substantially by manipulating the in-
spired oxygen fraction.
Therefore, we must distinguish between oxygen ten-
sion, which responds impressively to changes in inspired
oxygen fraction, and oxygen content and delivery, which
show a negligible change in response to hyperoxia, but
are the key factors for sustaining aerobic metabolism.
It has been recently suggested that increasing ptiO2 by
ventilation with pure oxygen may have a beneficial ef-
fect on brain dysoxia (Menzel et al., 1999). The as-
sumption is that simply increasing ptiO2 in the tissue
might increase the driving force of O2 flux from the cap-
illary to the mitochondria and might then cause a shift
from anaerobic to aerobic metabolism.
Our AVDO2 data, however difficult to interpret, do
not seem to confirm this. AVDO2 indicates the cou-
pling, or the lack of coupling, between CBF and O2
metabolism (CMRO2) and clearly illustrated the
match/mismatch between O2 supply and demand dur-
ing the three phases of intact, moderately and severely
impaired CBF. However, at least in the first two phases,
AVDO2 decreased after hyperoxia was induced. The
relationship among CBF, CMRO2 and AVDO2 can be
expressed as AVDO2 5 CMRO2/CBF. It follows that
if AVDO2 decreases, this may be due to an increase in
CBF or a decrease in CMRO2. In our conditions, CBF
fell slightly during hyperoxia, so a decrease in CMRO2
may explain the AVDO2 data. This makes it difficult
to find an agreement between the drop in AVDO2 and
the theoretical restoration of oxidative phosphorylation
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FIG. 8. Arteriovenous oxygen difference (AVDO2) and brain oxygen delivery (DO2) during normoxia and hyperoxia. 
*p , 0.05 (paired t test between AVDO2 in normoxia and in hyperoxia during the same CBF step).
induced by the elevation of ptiO2 in response to arter-
ial hyperoxia, which would have led to an increase of
CMRO2.
On the other hand, as CBF declined in line with the
institution of hyperoxia, a reduction of CMRO2 can only
be inferred to explain the reduction of AVDO2. Impaired
glucose uptake and oxidation, probably due to interfer-
ence with the pyruvate oxidase system, was found dur-
ing ventilation with oxygen at 1 and 2 atmospheres (Ja-
cobson et al., 1964). However, we believe that this needs
further investigation using more direct methods to study
cerebral metabolism.
Besides the results need to be repeated in animals who
have undergone traumatic brain injury, since the cerebral
metabolic derangements occurring after head trauma,
may affect the response to arterial hyperoxia.
In conclusion, ptiO2 reductions closely reflect the im-
balance between oxygen delivery and demand; this im-
plies a link between low ptiO2 and defective O2 supply
due to impaired CBF. However, this relation is not nec-
essarily reciprocal, since manipulating brain oxygen ten-
sion does not always influence brain oxygen delivery, as
in the case of ventilation with pure oxygen. Though the
effects of arterial hyperoxia on brain metabolism need
more study, we believe that for the time being at least
the ptiO2 response to hyperoxia may be useful for in-
vestigating O2 diffusion impairment with respect to the
spatial distribution of the brain microvasculature, but not
for restoring oxidative metabolism.
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